Home › Chronic Inflammatory Demyelinating Polyradiculoneuropathy › Connecticut › New Haven
Chronic Inflammatory Demyelinating Polyradiculoneuropathy clinical trials in New Haven, CT
5 studies for Chronic Inflammatory Demyelinating Polyradiculoneuropathy are looking for participants at sites in and around New Haven (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 2
- Site Number - 1621, New Haven
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
RecruitingPhase 3
- Yale University School of Medicine- Site Number : 8400018, New Haven
A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
RecruitingPhase 3
- Cinical Study Site, New Haven
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
RecruitingPhase 3
- Yale University School of Medicine, New Haven
A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care
RecruitingObservational study
- Yale School Of Medicine, New Haven
Chronic Inflammatory Demyelinating Polyradiculoneuropathy trials in other cities
- New York City, NY7 studies
- Houston, TX6 studies
- Miami, FL6 studies
- Indio, CA5 studies
- St. Louis, MO5 studies
- Kansas City, KS5 studies
- Philadelphia, PA5 studies
- San Francisco, CA4 studies
- Washington, DC4 studies
- Tampa, FL4 studies
- Birmingham, AL4 studies
- Orlando, FL4 studies
Other studies in New Haven
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer38 studies
- Cancer (all types)33 studies
- Metastatic Cancer23 studies
- Lung Cancer22 studies
- Head and Neck Squamous Cell Carcinoma22 studies
- Ovarian Cancer21 studies
- Colorectal Cancer20 studies
- Prostate Cancer20 studies
- Acute Myeloid Leukemia17 studies
- Alcohol Use Disorder (AUD)17 studies
- Opioid Overdose17 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.